Bliss GVS Pharma Completes Ownership Transition and Promoter Reclassification
Bliss GVS Pharma Ltd 路 Outcome 路 29 Sept 2026, 2:23 am
Bliss GVS Pharma Completes Ownership Transition and Promoter Reclassification Bliss GVS Pharma鈥檚 Board approved the reclassification of its outgoing promoter group to the "public" category on 28th Sep'26, following the consummation of the SPA dated 23rd May'26 and completion of the mandatory open offer. Anupam Rasayan India and PAC (Mates Visa Consultancy) acquired control, reducing the outgoing promoter group's aggregate shareholding from 34.82% (3,71,30,124 shares) to 0.01% (8,100 shares). The transaction formally transfers operational and managerial control to the incoming acquirers under SEBI Listing Regulations.
Original exchange filing (PDF)
More announcements from Bliss GVS Pharma Ltd
- Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations. 路 06 Nov 2026
- We wish to inform you that Asterisk Lifesciences Ltd, UK, a wholly owned subsidiary of Bliss GVS Pharma Limited, has obtained marketing authorization from the Medicines & Healthcare products .... 路 04 Nov 2026
- Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29, 2026, the members has granted 2,95,000 stock options under Bliss .... 路 29 Oct 2026
- Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026 路 29 Oct 2026
- Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026 路 29 Oct 2026
- Please find attached the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. 路 29 Oct 2026
- Bliss GVS Pharma Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 29 Oct 2026
